secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sonoma Pharmaceuticals, Inc. (SNOA)
CIK:        0001367083
Form:       8-K
Filed at:   2025-01-03T23:59:59+00:00
Accession:  0001683168-25-000076
Event type: other_material
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Sonoma Pharma grants 7,500 options to directors and 10,000 RSUs to each top executive
--------------------------------------------------------------------------------

- Non-employee directors each received 7,500 options at $2.68, vesting over three years.
- CEO Amy Trombly granted 10,000 RSUs; vesting at 6, 18, and 24 months.
- CFO Jerry Dvonch and COO Bruce Thornton each granted 10,000 RSUs with same vesting schedule.
- All awards vest upon change of control as part of annual equity grant program.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1367083/000168316825000076/0001683168-25-000076-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1367083/000168316825000076/sonoma_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-25-000076

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer